Keyphrases
RNA-based Therapy
100%
Proof of Concept Study
100%
Cryptosporidium Parvum
100%
Single Guide RNA (sgRNA)
100%
Argonaute
100%
Cryptosporidiosis
75%
Nucleoside Diphosphate Kinase
75%
Cryptosporidium
50%
Mouse Model
25%
Infected Cells
25%
Infectious Diseases
25%
FDA-approved Drugs
25%
Cause of Death
25%
Immunocompromised Patients
25%
In Vivo Model
25%
Antisense
25%
Intestinal Epithelial Cells
25%
RNA Interference
25%
Parasite Burden
25%
SCID Mice
25%
Days of Treatment
25%
Novel Therapies
25%
Acute Phase
25%
Oocyst Shedding
25%
Children under 5 Years
25%
Nitazoxanide
25%
Lipid Nanoparticles
25%
Diarrhea in children
25%
Antisense RNA
25%
Anticryptosporidial
25%
Moderate-to-severe Diarrhea
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cryptosporidiosis
100%
Single Stranded RNA
100%
Argonaute Protein
100%
Nucleoside Diphosphate Kinase
75%
Infection
50%
Cryptosporidium
50%
Mouse Model
25%
Diarrhea
25%
Oocyst
25%
Cryptosporidium parvum
25%
Complementary RNA
25%
Solid Lipid Nanoparticle
25%
Nitazoxanide
25%
SCID Beige Mouse
25%
Immunology and Microbiology
Cryptosporidium parvum
100%
Argonaute Protein
100%
Cryptosporidium
50%
Antisense
25%
Mouse Model
25%
Infectious Disease
25%
Parasite Load
25%
Oocyst
25%
Essential Gene
25%
SCID Beige Mouse
25%
RNAI
25%